Rivka Ayalon

972 total citations
17 papers, 641 citations indexed

About

Rivka Ayalon is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Rivka Ayalon has authored 17 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 7 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Rivka Ayalon's work include Renal Diseases and Glomerulopathies (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Rivka Ayalon is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Rivka Ayalon collaborates with scholars based in United States, Australia and Spain. Rivka Ayalon's co-authors include Laurence H. Beck, David J. Salant, Fernando C. Fervenza, S. Sethi, Pietro A. Canetta, Jai Radhakrishnan, Andrew S. Bomback, Gerald B. Appel, Nir Ayalon and Jill Downing and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and American Journal of Transplantation.

In The Last Decade

Rivka Ayalon

16 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rivka Ayalon United States	13	418	200	160	149	131	17	641
Helen Lovell United States	7	703 1.7×	141 0.7×	185 1.2×	144 1.0×	132 1.0×	8	833
Agnes Trautmann Germany	8	428 1.0×	130 0.7×	168 1.1×	109 0.7×	77 0.6×	10	581
Koji Tsugawa Japan	16	231 0.6×	82 0.4×	150 0.9×	45 0.3×	153 1.2×	51	564
Ilka Edenhofer Switzerland	12	401 1.0×	68 0.3×	258 1.6×	86 0.6×	112 0.9×	20	719
Lindi Jiang China	14	135 0.3×	172 0.9×	185 1.2×	72 0.5×	73 0.6×	22	638
Nataša Stajić Serbia	10	187 0.4×	106 0.5×	225 1.4×	47 0.3×	86 0.7×	24	535
Marta Christov United States	15	615 1.5×	129 0.6×	225 1.4×	145 1.0×	16 0.1×	18	802
Sean Barbour Canada	11	326 0.8×	89 0.4×	72 0.5×	97 0.7×	57 0.4×	41	456
Shigehiro Uezono Japan	11	156 0.4×	193 1.0×	165 1.0×	27 0.2×	38 0.3×	22	442
Y-L. Chan Taiwan	8	305 0.7×	103 0.5×	60 0.4×	94 0.6×	54 0.4×	12	447

Countries citing papers authored by Rivka Ayalon

Since Specialization

Citations

This map shows the geographic impact of Rivka Ayalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rivka Ayalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rivka Ayalon more than expected).

Fields of papers citing papers by Rivka Ayalon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rivka Ayalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rivka Ayalon. The network helps show where Rivka Ayalon may publish in the future.

Co-authorship network of co-authors of Rivka Ayalon

This figure shows the co-authorship network connecting the top 25 collaborators of Rivka Ayalon. A scholar is included among the top collaborators of Rivka Ayalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rivka Ayalon. Rivka Ayalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Solomon, Melinda, Philip E. Knapp, Hanni Menn‐Josephy, et al.. (2024). Nephrotic Syndrome as a Complication of Systemic Calcitonin Amyloidosis From Long-Standing Metastatic Medullary Thyroid Cancer. AACE Clinical Case Reports. 10(6). 244–248.

2.

Beck, Laurence H., et al.. (2019). Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatric Nephrology. 36(1). 19–30. 33 indexed citations

3.

Gupta, Gaurav, Rivka Ayalon, Jason M. Kidd, et al.. (2016). Pre‐transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post‐kidney transplantation. Clinical Transplantation. 30(4). 461–469. 44 indexed citations

4.

Kattah, Andrea G., Rivka Ayalon, Laurence H. Beck, et al.. (2015). Anti-Phospholipase A2 Receptor Antibodies in Recurrent Membranous Nephropathy. American Journal of Transplantation. 15(5). 1349–1359. 66 indexed citations

5.

Al‐Rabadi, Laith, Rivka Ayalon, Ramon Bonegio, et al.. (2015). Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. American Journal of Kidney Diseases. 67(5). 775–778. 19 indexed citations

6.

Hladunewich, Michelle, D C Cattran, Laurence H. Beck, et al.. (2014). A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy. Nephrology Dialysis Transplantation. 29(8). 1570–1577. 73 indexed citations

7.

Timmermans, Sjoerd A.M.E.G., Jan Damoiseaux, Rivka Ayalon, et al.. (2014). Evaluation of Anti-PLA2R1 as Measured by a Novel ELISA in Patients With Idiopathic Membranous Nephropathy. American Journal of Clinical Pathology. 142(1). 29–34. 59 indexed citations

8.

Ayalon, Rivka & Laurence H. Beck. (2013). Membranous nephropathy: not just a disease for adults. Pediatric Nephrology. 30(1). 31–39. 42 indexed citations

9.

Saeki, Takako, et al.. (2013). Development of IgG4-related disease in a patient diagnosed with idiopathic membranous nephropathy. Clinical Kidney Journal. 6(5). 486–490. 13 indexed citations

10.

Gopal, Deepa M., Nir Ayalon, Rivka Ayalon, et al.. (2013). Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure. Journal of the American Heart Association. 2(3). 6 indexed citations

11.

Ayalon, Rivka, Laurence H. Beck, David J. Salant, et al.. (2012). Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A2 receptor antibody-positive membranous nephropathy. Clinical Kidney Journal. 5(2). 162–165. 6 indexed citations

12.

Bomback, Andrew S., Pietro A. Canetta, Laurence H. Beck, et al.. (2012). Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial. American Journal of Nephrology. 36(1). 58–67. 65 indexed citations

13.

Blosser, Christopher D., Rivka Ayalon, Rajesh Nair, Christie P. Thomas, & Laurence H. Beck. (2012). Very Early Recurrence of Anti-Phospholipase A2 Receptor-Positive Membranous Nephropathy After Transplantation. American Journal of Transplantation. 12(6). 1637–1642. 26 indexed citations

14.

Ayalon, Rivka, Laurence H. Beck, David J. Salant, et al.. (2012). Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A2 receptor antibody-positive membranous nephropathy. Clinical Kidney Journal. 5(2). 162–165. 11 indexed citations

15.

Gopal, Deepa M., Nir Ayalon, Rivka Ayalon, et al.. (2012). Relationship of Plasma Galectin‐3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure. Journal of the American Heart Association. 1(5). e000760–e000760. 105 indexed citations

16.

Khosroshahi, Arezou, Rivka Ayalon, Laurence H. Beck, et al.. (2012). IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor. International Journal of Rheumatology. 2012. 1–6. 33 indexed citations

17.

Schwartz, Idit F., Rivka Ayalon, Tamara Chernichovski, et al.. (2006). Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats. Kidney International. 69(2). 298–303. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact